共 29 条
[2]
Balducci Lodovico, 2007, Cancer Control, V14, P7
[5]
Buske C, 2006, HAEMATOLOGICA, V91, P104
[10]
Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas:: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)
[J].
BLOOD,
2006, 108 (13)
:4003-4008